Minzhi Yu

1.8k total citations
38 papers, 1.3k citations indexed

About

Minzhi Yu is a scholar working on Immunology, Surgery and Molecular Biology. According to data from OpenAlex, Minzhi Yu has authored 38 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 10 papers in Surgery and 9 papers in Molecular Biology. Recurrent topics in Minzhi Yu's work include Nanoparticle-Based Drug Delivery (8 papers), RNA Interference and Gene Delivery (7 papers) and Cholesterol and Lipid Metabolism (6 papers). Minzhi Yu is often cited by papers focused on Nanoparticle-Based Drug Delivery (8 papers), RNA Interference and Gene Delivery (7 papers) and Cholesterol and Lipid Metabolism (6 papers). Minzhi Yu collaborates with scholars based in United States, China and Norway. Minzhi Yu's co-authors include Anna Schwendeman, Wenmin Yuan, Jiancheng Wang, Emily E. Morin, James J. Moon, Steven P. Schwendeman, Dan Li, Rui Kuai, Qiang Zhang and Chong Qiu and has published in prestigious journals such as Journal of Biological Chemistry, ACS Nano and Biomaterials.

In The Last Decade

Minzhi Yu

34 papers receiving 1.3k citations

Peers

Minzhi Yu
Xin Wei United States
Jeong Uk Choi South Korea
Xiao Xu China
Jia Guo China
Janet L. Markman United States
Md. Nazir Hossen United States
Xin Wei United States
Minzhi Yu
Citations per year, relative to Minzhi Yu Minzhi Yu (= 1×) peers Xin Wei

Countries citing papers authored by Minzhi Yu

Since Specialization
Citations

This map shows the geographic impact of Minzhi Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minzhi Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minzhi Yu more than expected).

Fields of papers citing papers by Minzhi Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minzhi Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minzhi Yu. The network helps show where Minzhi Yu may publish in the future.

Co-authorship network of co-authors of Minzhi Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Minzhi Yu. A scholar is included among the top collaborators of Minzhi Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Minzhi Yu. Minzhi Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Yaozhong, Minzhi Yu, Huilun Wang, et al.. (2025). Restoring Vascular Smooth Muscle Cell Mitochondrial Function Attenuates Abdominal Aortic Aneurysm in Mice. Arteriosclerosis Thrombosis and Vascular Biology. 45(4). 523–540.
2.
Lu, Ziyi, et al.. (2025). A Comparative Study on Physicochemical and Analytical Characterizations of Doxil® and its Generic Drug Products. The AAPS Journal. 27(4). 100–100. 1 indexed citations
3.
Ackermann, Rose, Minzhi Yu, Xinye Wang, et al.. (2024). Reverse engineering of Onivyde® – Irinotecan liposome injection. International Journal of Pharmaceutics. 669. 125000–125000. 6 indexed citations
4.
Yu, Minzhi, Yayuan Liu, Wenmin Yuan, et al.. (2024). Development of an Accelerated Rotator-based Drug Release Method for the Evaluation of Bupivacaine Multivesicular Liposomes. Pharmaceutical Research. 41(2). 293–303. 2 indexed citations
5.
Li, Ji, et al.. (2024). Challenges in the development of long acting injectable multivesicular liposomes (DepoFoam® technology). European Journal of Pharmaceutics and Biopharmaceutics. 205. 114577–114577. 6 indexed citations
6.
Aizenshtadt, Aleksandra, Minzhi Yu, Anna Schwendeman, et al.. (2023). Quantitative chemometric phenotyping of three-dimensional liver organoids by Raman spectral imaging. Cell Reports Methods. 3(4). 100440–100440. 18 indexed citations
7.
Yu, Minzhi, Wenmin Yuan, Yayuan Liu, et al.. (2023). Characterization of exparel bupivacaine multivesicular liposomes. International Journal of Pharmaceutics. 639. 122952–122952. 21 indexed citations
8.
Mei, Ling, Minzhi Yu, Yayuan Liu, et al.. (2022). Synthetic high-density lipoprotein nanoparticles delivering rapamycin for the treatment of age-related macular degeneration. Nanomedicine Nanotechnology Biology and Medicine. 44. 102571–102571. 15 indexed citations
9.
Yuan, Wenmin, Rui Kuai, Emily E. Morin, et al.. (2022). Systematic evaluation of the effect of different apolipoprotein A-I mimetic peptides on the performance of synthetic high-density lipoproteins in vitro and in vivo. Nanomedicine Nanotechnology Biology and Medicine. 48. 102646–102646. 10 indexed citations
10.
Michell, Danielle L., Ryan M. Allen, Minzhi Yu, et al.. (2022). Elucidation of physico-chemical principles of high-density lipoprotein–small RNA binding interactions. Journal of Biological Chemistry. 298(6). 101952–101952. 6 indexed citations
11.
Guo, Yanhong, Huilun Wang, Minzhi Yu, et al.. (2021). Phospholipid nanoparticles: Therapeutic potentials against atherosclerosis via reducing cholesterol crystals and inhibiting inflammation. EBioMedicine. 74. 103725–103725. 21 indexed citations
12.
Scheetz, Lindsay, Minzhi Yu, Dan Li, et al.. (2020). Synthetic HDL Nanoparticles Delivering Docetaxel and CpG for Chemoimmunotherapy of Colon Adenocarcinoma. International Journal of Molecular Sciences. 21(5). 1777–1777. 29 indexed citations
13.
Zhang, Haitao, Minzhi Yu, Yujie Niu, et al.. (2020). Polyarginine-Mediated siRNA Delivery: A Mechanistic Study of Intracellular Trafficking of PCL-R15/siRNA Nanoplexes. Molecular Pharmaceutics. 17(5). 1685–1696. 11 indexed citations
14.
Yuan, Wenmin, Bilian Yu, Minzhi Yu, et al.. (2020). Synthetic high-density lipoproteins delivering liver X receptor agonist prevent atherogenesis by enhancing reverse cholesterol transport. Journal of Controlled Release. 329. 361–371. 33 indexed citations
15.
Wang, Ton, Chitra Subramanian, Minzhi Yu, et al.. (2019). Mimetic sHDL nanoparticles: A novel drug-delivery strategy to target triple-negative breast cancer. Surgery. 166(6). 1168–1175. 10 indexed citations
16.
Yu, Minzhi, Wenmin Yuan, Dan Li, Anna Schwendeman, & Steven P. Schwendeman. (2019). Predicting drug release kinetics from nanocarriers inside dialysis bags. Journal of Controlled Release. 315. 23–30. 145 indexed citations
17.
Kuai, Rui, Xiaoqi Sun, Wenmin Yuan, et al.. (2018). Dual TLR agonist nanodiscs as a strong adjuvant system for vaccines and immunotherapy. Journal of Controlled Release. 282. 131–139. 110 indexed citations
18.
Yu, Minzhi, et al.. (2018). Battle of GLP-1 delivery technologies. Advanced Drug Delivery Reviews. 130. 113–130. 116 indexed citations
19.
Lin, Wei, et al.. (2016). Brain tumor-targeted therapy by systemic delivery of siRNA with Transferrin receptor-mediated core-shell nanoparticles. International Journal of Pharmaceutics. 510(1). 394–405. 112 indexed citations
20.
Yu, Minzhi, Ting Yang, Jiancheng Wang, et al.. (2016). Systemic delivery of siRNA by T7 peptide modified core-shell nanoparticles for targeted therapy of breast cancer. European Journal of Pharmaceutical Sciences. 92. 39–48. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026